Working… Menu

Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03848806
Recruitment Status : Completed
First Posted : February 21, 2019
Last Update Posted : February 21, 2019
Information provided by (Responsible Party):
Haus Bioceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 11, 2016
Actual Study Completion Date : September 5, 2016